Nine things to know about Teladoc’s first-quarter revenue, per its April 25 earnings report:
- Teladoc posted a first-quarter net loss of $82 million, compared to a $69 million loss in the first quarter of 2023.
- Teladoc’s access fee revenue increased by 1% to $557 million.
- Other revenue saw growth of 14% to $89 million.
- U.S. revenue experienced 1% growth, reaching $548 million.
- International revenue grew 13% to $99 million.
- Teladoc’s integrated care segment — catering to health plans, employers and health systems — generated $377 million, marking an 8% increase from 2023.
- Membership in the integrated care segment grew by 8%, totaling 92 million.
- Membership in Teladoc’s chronic care program grew by 9%, reaching 1.1 million.
- Revenue for Teladoc’s virtual mental health segment, BetterHelp, dropped 4% to $269 million due to a decrease in paying users and increased customer acquisition expenses.
The release of the earnings report comes shortly after the company announced that its CEO, Jason Gorevic, is leaving his role, effective immediately.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
